In this study, we identified IGF2BP1, IGF2BP3 and PRMT5 as the bona fide interacting partners of LINC01138 and demonstrated the oncogenic function of the IGF2BP1/IGF2BP3- LINC01138-PRMT5 axis in HCC cells. This evidence concerns the gene IGF2BP1 and hepatocellular carcinoma.